Cardiac Biomarkers Market Will Reach 20,718.8 Million by 2030 | P&S Intelligence

According to the latest market research study published by P&S Intelligence, the cardiac biomarkers market will generate a value of USD 20,718.8 million by 2030, powering at a compound annual growth rate of 10.5% by the end of this decade. This is because of the growing incidence of ACS, tech progressions in cardiac biomarkers, increasing demand for point-of-care testing kits, and requirement for high specificity in the recognition of cardiac disorders, chiefly myocardial infarction.

Troponin had the major revenue share of, more than 35%, in the recent past, and this will grow at a considerable rate by the end of this decade as well. This is because of the extraordinary specificity and capacity of their protein complex to support cardiac problems, for example ACS, more precisely.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/cardiac-biomarker-market/report-sample

Moreover, the high occurrence of myocardial infarction will power the industry, as troponin is the most-common tool for detecting this condition. Also, the myocardial muscle creatine kinase category will power significantly followed by troponin, in the years to come.

The North America industry had the largest revenue share, of more than 35%, in 2021. The dominance is because of the increasing use of biomarkers for precision medicine, diverse growth strategies realized by players of the industry, and snowballing acceptance of biomarkers detecting cardiac diseases.

Browse full report at: https://www.psmarketresearch.com/market-analysis/cardiac-biomarker-market

The U.S is a major revenue contributor in North America as it is the base for numerous market players and has a high R&D spending on the healthcare industry.

There has been an increase in the number of people who are suffering with acute coronary syndrome, and because of this the demand for cardiac biomarkers will continue to grow in the years to come.

Cardiac Biomarkers Market Size Breakdown by Segment

By Type
• Troponins
• Myocardial Muscle Creatine Kinase
• Myoglobin
• BNPs
• IMA
• ALT/AST
• Others
By Application
• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Others
By Testing Location
• Laboratory Testing
• Point-of-Care Testing
Regional Analysis
• North America Cardiac Biomarkers Market
o By type
o By application
o By testing location
o By country - U.S. and Canada
• Europe Cardiac Biomarkers Market
o By type
o By application
o By testing location
o By country - Germany, France, U.K., Italy, Spain, and Rest of Europe
• Asia-Pacific (APAC) Cardiac Biomarkers Market
o By type
o By application
o By testing location
o By country - China, India, Japan, South Korea, Australia, and Rest of APAC
• Latin America (LATAM) Cardiac Biomarkers Market
o By type
o By application
o By testing location
o By country - Brazil, Mexico, and Rest of LATAM
• Middle East and Africa (MEA) Cardiac Biomarkers Market
o By type
o By application
o By testing location
o By country - Saudi Arabia, South Africa, and Rest of MEA

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
LinkedIn: https://www.linkedin.com/company/pnsintelligence

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

This release was published on openPR.